# Mexico pharmaceutical industry and healthcare spending > Live situation record from CLSTR: https://clstr.news/situations/mexico-pharmaceutical-industry-and-healthcare-spending > Updated: 2026-08-12T13:50:39.000Z. Sources: 3. Developments: 2. Mexico is facing significant financial and logistical challenges regarding its pharmaceutical sector and public health infrastructure. The federal government has proposed a new labeling requirement for medicines under the 2027–2028 consolidated procurement program. Rafael Gual, director general of Canifarma, warned that this mandate could cost the industry approximately 10 billion pesos and stated, “Sí, ralentizaría totalmente el proceso de entrega de los medicamentos,” suggesting it would “tener un costo brutal para la industria.” Simultaneously, the costs for the nation’s Megafarmacia project are projected to rise to 17.635 billion pesos by 2026, a 39% increase over 2024 estimates. Data from the Secretaría de Hacienda y Crédito Público indicates discrepancies in previous cost reports, noting that while initial estimates were lower, the actual investment to start operations was 3.948 billion pesos. Reports also highlight infrastructure concerns at the Huehuetoca site, including a sinkhole that was reportedly blocked with rubble rather than repaired. ## Timeline ### 2026-08-12: Mexico Megafarmacia project costs projected to rise to 17.6 billion pesos Mexico's Megafarmacia project cost is projected to rise to 17.6 billion pesos by 2026, a 39% increase from 2024 estimates, according to SHCP data. 3 sources. https://clstr.news/cluster/mexico-megafarmacia-project-costs-projected-to-rise-to-176-billion-pesos ### 2026-08-01: Mexico's drug labeling plan could cost industry 10 billion pesos Mexico's new drug‑labeling rule for 2027‑28 purchases could cost pharma firms 10 billion pesos, delay supply and deter participation, according to industry leader Rafael Gual. 4 sources. https://clstr.news/cluster/mexicos-drug-labeling-plan-could-cost-industry-10-billion-pesos --- Cite as: Mexico pharmaceutical industry and healthcare spending. CLSTR, https://clstr.news/situations/mexico-pharmaceutical-industry-and-healthcare-spending